|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Revenue from contract with customer | |||||
| Product | |||||
| Fees and other revenues | |||||
| Premiums | |||||
| Net investment income | |||||
| TOTAL REVENUES | |||||
| Benefits and expenses | |||||
| Pharmacy and other service costs | |||||
| Medical costs and other benefit expenses | |||||
| Selling, general and administrative expenses | |||||
| Amortization of acquired intangible assets | |||||
| TOTAL BENEFITS AND EXPENSES | |||||
| Income from operations | |||||
| Interest expense and other | |||||
| Debt extinguishment gain | |||||
| Net gain (loss) on sale of businesses | |||||
| Net investment losses | |||||
| Income before income taxes | |||||
| TOTAL INCOME TAXES | |||||
| Net income | |||||
| Less: Net income attributable to noncontrolling interests | |||||
| SHAREHOLDERS' NET INCOME | |||||
| Shareholders' net income per share | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) |
Loading...
